Bela Kelety

Bela Kelety has been working in the biotechnology field since 1992. Bela began as a PhD student at the Max-Planck-Institute of Biophysics, followed by a post doc at HMR (now sanofi-aventis) in 1996. In 1998, they became the Head of Laboratory at Intervet and then worked as a Consultant at CATBera GmbH in 2009. In the same year, they also began their own consulting business, Bela Kelety Consulting. In 2010, they became Manager of Strategic Projects at BRAIN AG and in 2012, they were appointed CEO of Mekon Science Networks GmbH. Most recently, in 2018, they were named Chief Technology Officer at SolasCure.

Bela Kelety attended Technische Universität Darmstadt from 1986 to 1991, where they earned a Dipl Ing in Chemistry.